BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12209693)

  • 1. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
    Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
    Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
    Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
    Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R
    Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters.
    Hulkkonen J; Vilpo J; Vilpo L; Koski T; Hurme M
    Haematologica; 2000 Jun; 85(6):600-6. PubMed ID: 10870116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
    Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
    Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
    Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
    Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
    Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
    Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
    Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
    Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
    Rivkina A; Vitols G; Murovska M; Lejniece S
    Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukins, TNF-alpha and beta-2M in patients with B cell chronic lymphocytic leukemia.
    Mavridis AK; Tsiara S; Makis A; Chaidos A; Christou L; Seferiadis K; Bourantas KL
    J Exp Clin Cancer Res; 1998 Dec; 17(4):445-8. PubMed ID: 10089066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
    Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
    Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
    Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.